evaluating the presence of deregulated tumoral onco-micrornas in serum-derived exosomes of gastric cancer patients as noninvasive diagnostic biomarkers

introduction: exosomal micrornas (mirnas) are emerging diagnostic biomarkers for different types of cancers. we aim to detect gastric cancer (gc)-specific mirnas in serum exosomes with diagnostic potential. methods: a pair of 43 tumor and tumoradjacent tissue biopsies obtained from gc patients, also 5 ml peripheral blood (following 12h fasting) were collected from the same patients and healthy controls (hcs). qiagen mircury lna mirna focus pcr panel applied to screen differentially expressed onco-mirnas. the candidate mirnas with the highest fold changes proceeded for validation by qrt-pcr in individuals. results: we identified that exosomal mir-10a-5p, mir-19b-3p, mir-215-5p, and mir-18a-5p were significantly upregulated in gc patient’s exosomes in contrast to hcs exosomes, roc curve analysis indicated area under the roc curve (auc) of 0.801, 0.721, 0.780 and 0.736 respectively. the roc curve analysis for the combined signature of four exosomal mirnas indicated auc of 0.813. also, spearman s correlation coefficients indicated that the mirna expression is highly correlated between tumor and exosome. conclusion: herein, we specifically identified four mirnas in serum exosomes of gc patients for a diagnostic purpose which are directly associated with tumoral mirna expression profile